EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Type 2 diabetes pathway-specific polygenic risk scores elucidate heterogeneity in clinical presentation, disease progression and diabetic complications in 18,217 Chinese individuals with type 2 diabetes

Gechang Yu, Claudia H T Tam, Cadmon K P Lim, Mai Shi, Eric S H Lau, Risa Ozaki, Heung-Man Lee, Alex C W Ng, Yong Hou, Baoqi Fan, Chuiguo Huang, Hongjiang Wu und 30 weitere

Diabetologia · 2025-03 · 68 (3) · 602-614

DOI: 10.1007/s00125-024-06309-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetologia, online erschienen am 12.11.2024. Verfasst von Gechang Yu und 41 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China. Hauptthemen laut MEDLINE: Diabetes Complications, Diabetes Mellitus, Type 2, Multifactorial Inheritance. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese University of Hong Kong, Research Grants Council, University Grants Committee, Food and Health Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/hypothesis Type 2 diabetes is a complex and heterogeneous disease and the aetiological components underlying the heterogeneity remain unclear in the Chinese and East Asian population. Therefore, we aimed to investigate whether specific pathophysiological pathways drive the clinical heterogeneity in type 2 diabetes.

Methods

We employed newly developed type 2 diabetes hard-clustering and soft-clustering pathway-specific polygenic risk scores (psPRSs) to characterise individual genetic susceptibility to pathophysiological pathways implicated in type 2 diabetes in 18,217 Chinese patients from Hong Kong. The ‘total’ type 2 diabetes polygenic risk score (PRS) was summed by genome-wide significant type 2 diabetes signals ( n =1289). We examined the associations between psPRSs and cardiometabolic profile, age of onset, two glycaemic deterioration outcomes (clinical requirement of insulin treatment, defined by two consecutive HbA 1c values ≥69 mmol/mol [8.5%] more than 3 months apart during treatment with two or more oral glucose-lowering drugs, and insulin initiation), three renal (albuminuria, end-stage renal disease and chronic kidney disease) outcomes and five cardiovascular outcomes.

Results

Although most psPRSs and total type 2 diabetes PRS were associated with an earlier and younger onset of type 2 diabetes, the psPRSs showed distinct associations with clinical outcomes. In particular, individuals with normal weight showed higher psPRSs for beta cell dysfunction and lipodystrophy than those who were overweight. The psPRSs for obesity were associated with faster progression to clinical requirement of insulin treatment (adjusted HR [95% CI] 1.09 [1.05, 1.13], p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes ComplicationsDiabetes Mellitus, Type 2Multifactorial InheritanceAdultAgedFemaleHumansMaleMiddle AgedDisease ProgressionGenetic Predisposition to DiseaseGenetic Risk ScoreGenome-Wide Association StudyHong KongRisk FactorsEast Asian People

Stichwörter der Autor:innen

Chinese populationDiabetic complicationsDisease progressionHeterogeneityPathway-specific polygenic risk scoreType 2 diabetes

Autor:innen und Institutionen

  • Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
  • Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, China.
  • CUHK-SJTU Joint Research Centre in Diabetes Genomics and Precision Medicine, The Chinese University of Hong Kong, Hong Kong, China.
  • Laboratory for Molecular Epidemiology in Diabetes, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China.
  • Diabetes Research Laboratory, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China.
  • Department of Medicine and Geriatrics, Kwong Wah Hospital, Hong Kong, China.

Förderung

  • Chinese University of Hong Kong
  • Research Grants Council, University Grants Committee
  • Food and Health Bureau
  • Croucher Foundation
  • a research grant from Randox Ltd (to R.A.O.) on autoimmune disease genetic risk score diagnostics

Zitieren

APA

Yu, G., Tam, C. H. T., Lim, C. K. P., Shi, M., Lau, E. S. H., Ozaki, R., Lee, H. M., Ng, A. C. W., Hou, Y., Fan, B., Huang, C., Wu, H., Yang, A., Cheung, H. M., Lee, K. F., Siu, S. C., Hui, G., Tsang, C. C., Lau, K. P., …, & TRANSCEND Consortium (2025). Type 2 diabetes pathway-specific polygenic risk scores elucidate heterogeneity in clinical presentation, disease progression and diabetic complications in 18,217 Chinese individuals with type 2 diabetes. Diabetologia, 68(3), 602-614. https://doi.org/10.1007/s00125-024-06309-y

Vancouver

Yu G, Tam CHT, Lim CKP, Shi M, Lau ESH, Ozaki R, et al. Type 2 diabetes pathway-specific polygenic risk scores elucidate heterogeneity in clinical presentation, disease progression and diabetic complications in 18,217 Chinese individuals with type 2 diabetes. Diabetologia. 2025;68(3):602-614. doi:10.1007/s00125-024-06309-y

BibTeX
@article{Yu2025,
  author = {Yu, Gechang and Tam, Claudia H T and Lim, Cadmon K P and Shi, Mai and Lau, Eric S H and Ozaki, Risa and Lee, Heung-Man and Ng, Alex C W and Hou, Yong and Fan, Baoqi and Huang, Chuiguo and Wu, Hongjiang and Yang, Aimin and Cheung, Hoi Man and Lee, Ka Fai and Siu, Shing Chung and Hui, Grace and Tsang, Chiu Chi and Lau, Kam Piu and Leung, Jenny Y Y and Cheung, Elaine Y N and Tsang, Man Wo and Kam, Grace and Lau, Ip Tim and Li, June K Y and Yeung, Vincent T F and Lau, Emmy and Lo, Stanley and Fung, Samuel and Cheng, Yuk Lun and Szeto, Cheuk Chun and Hong Kong Diabetes Biobank Study Group, Hong Kong Diabetes Biobank Study Group and Chow, Elaine and Kong, Alice P S and Tam, Wing Hung and Luk, Andrea O Y and Weedon, Michael N and So, Wing-Yee and Chan, Juliana C N and Oram, Richard A and Ma, Ronald C W and TRANSCEND Consortium, TRANSCEND Consortium},
  title = {Type 2 diabetes pathway-specific polygenic risk scores elucidate heterogeneity in clinical presentation, disease progression and diabetic complications in 18,217 Chinese individuals with type 2 diabetes},
  journal = {Diabetologia},
  year = {2025},
  volume = {68},
  number = {3},
  pages = {602--614},
  doi = {10.1007/s00125-024-06309-y}
}
Kostenlos starten →